| Previous Close | 0.7500 |
| Open | 0.7500 |
| Bid | 0.7200 x 0 |
| Ask | 0.7800 x 0 |
| Day's Range | 0.7500 - 0.7500 |
| 52 Week Range | 0.3600 - 0.7700 |
| Volume | 2,500 |
| Avg. Volume | 15,240 |
| Market Cap | 37.548M |
| Beta (5Y Monthly) | 0.33 |
| PE Ratio (TTM) | 9.38 |
| EPS (TTM) | 0.0800 |
| Earnings Date | Apr. 17, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 18, 2005 |
| 1y Target Est | 0.90 |
- CNW Group
Imaflex Announces that the ADVASEAL® Release Study is Underway
Independent trial results expected for November 2020MONTREAL, Oct. 8, 2020 /CNW Telbec/ - Imaflex Inc.
- CNW Group
Imaflex Reports Positive Final Independent Results from ADVASEAL® Efficacy Field Trial
ADVASEAL shown to be effective fumigant replacement Treatment comparison: ADVASEAL® versus best grower fumigation standard * ADVASEAL® plots producing comparable marketable yields to current grower standard * Significant grower savings and environmental benefits over conventional fumigation * Trial further demonstrates ADVASEAL's® potential as a next generation clean technologyMONTREAL, Sept. 10, 2020 /CNW Telbec/ - Imaflex Inc.
- Simply Wall St.
What Do The Returns At Imaflex (CVE:IFX) Mean Going Forward?
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
© 2020 Verizon Media. All rights reserved.
